Last updated: March 27, 2023
Sponsor: State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sleep Apnea Syndromes
Treatment
N/AClinical Study ID
NCT05033626
NMSC-02-21
Ages 30-60 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The patient understands the essence of all procedures planned in the framework of aninitiative clinical trial and voluntarily confirms his desire to participate bywritten informed consent;
- Male or female patients with completed skeletal growth at the age of 30 to 60 years,inclusively, with thyroid pathology and moderate to severe OSAS according tocardiorespiratory monitoring with obstruction of the soft tissues of the upperrespiratory tract at the levels of the oropharyngeal and laryngopharynx, withoutradiography of the pathology of the paranasal sinuses;
- Еhe patient is scheduled for thyroid gland surgery (thyroidectomy with / withoutlymphadenectomy, subtotal resection of the thyroid gland, hemithyroidectomy).
Exclusion
Exclusion Criteria:
- Women during pregnancy, childbirth;
- Women during breastfeeding;
- Persons with mental disorders;
- Persons detained, taken into custody, serving a sentence in the form of restriction offreedom, arrest, imprisonment or administrative arrest;
- Chronic somatic diseases in the stage of decompensation. Conditions and concomitantpathology of other organs, which are a contraindication for general anesthesia andintubation;
- Diseases and conditions associated with severe bleeding disorders (hemophilia, vonWillebrand disease, deficiency of one or more coagulation factors, etc.);
- Infectious diseases in the acute stage.
- Severe brain injuries, which entailed consequences in the form of focal epilepsy,encephalopathy, dementia;
- Pathology of the paranasal sinuses according to X-ray data;
- Pathologies that are relative contraindications for CPAP therapy (bullous lungdisease; pulmonary emphysema; a history of pneumothorax, pneumomediastinum,pneumocephalus, respiratory distress syndrome, external liquorrhea; previous surgicalinterventions on the brain, middle or inner ear, pituitary gland; recurrent sinusitis;recurrent eye infections; severe hypotension; severe dehydration; frequent nosebleeds;fractures of the bones of the face; condition after esophagectomy in history (risk ofdamage to the anastomosis due to increased pharyngeal / esophageal pressure);hemodynamic instability; a history of severe chronic heart failure; Decompensation ofmajor diseases; cardiomyopathy of any genesis; oncological diseases (except forpathology of the thyroid gland);
- Pathologies that are absolute contraindications for CPAP therapy (unconsciousness ofthe patient; severe respiratory failure, which may require intubation and subsequentmechanical ventilation; cerebrospinal fluid fistula; collapse of the epiglottisaccording to sleep endoscopy);
- refusal of the patient to carry out CPAP therapy.
Study Design
Total Participants: 10
Study Start date:
October 15, 2021
Estimated Completion Date:
May 01, 2024
Study Description
Connect with a study center
Pirogov National Medical and Surgical Center
Moscow, 105203
Russian FederationActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.